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[Background & Objective] 
Increased production of reactive oxygen species (ROS) during oxidative stress has 
been associated with a number of age-related degenerative diseases, cancer, 
cardiovascular diseases, and neurological disorders.  ROS exhibit facile reactivity with 
DNA bases, proteins, and polyunsaturated fatty acids (PUFAs).  Linoleic acid (LA), one 
of representative PUFAs, can be converted to hydroperoxides (13-hydroperoxy-9,11 
(Z,E)-octadecadienoic acid, 13-HPODE), which undergo homolytic decomposition to 
bifunctional electrophiles such as 4-oxo-2(E)-nonenal (ONE).  These reactive aldehydes 
are involved in protein dysfunctions and altered gene regulations through the 
modification of amino acid residues and crosslinking of proteins.  Thus, there have 
been intensive efforts to ascertain the structural nature of lipid hydroperoxide-mediated 
protein modifications, followed by detecting them in biological samples.  However, 
most previous studies have focused on either the structural characterization of 
modifications on a model amino acid or the analysis of protein modification by a single 
electrophile because of the difficulties in dealing with complex samples.  Therefore, it 
is required to conduct a comprehensive study 
of the protein modifications that result from 
various peroxidation products of PUFAs.  In 
my proposal, following approaches (Figure 1) 
have been applied to find novel biomarkers for 
lipid peroxidation and improve understanding 
of the relationship between lipid 
hydroperoxide-mediated protein modifications 
and degenerative diseases: i) A bioactive 
peptide, angiotensin (Ang) II (DRVYIHPF), 
was employed to characterize its modification 
by multiple electrophiles [1, 2].  ii) Based on the results, the proteomic methodology 
was developed for the screening of lipid hydroperoxide-mediated protein modification 
using an isotope data dependent scan (IDDS) and stable isotope labeling by fatty acid in 
Figure 1. Outline of the current study. i) Identification of lipid-derived 
modifications to Ang II, ii) Development of IDDS and SILFAC, and iii) 
Screening of  modified protein in the cell system. 
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cell culture (SILFAC).  iii) The developed methodology was then applied to screen out 
modified proteins in MCF-7 cells subjected to conditions of oxidative stress.  
 
[Methods] 
Ang II was allowed to react with ONE, 4-hydroxy-2(E)-nonenal (HNE), 
4,5-epoxy-2(E)-decenal (EDE) or 4-hydroperoxy-2(E)-nonenal (HPNE).  Each reaction 
mixture was analyzed by liquid chromatography (LC)-ultraviolet (UV), matrix-assisted 
laser desorption ionization (MALDI)/time-of-flight (TOF)-mass spectrometry (MS), and 
LC/electrospray ionization (ESI)-MS to identify modified Ang II.  MALDI/postsource 
decay TOF-MS and tandem mass spectrometry (MS/MS) were also performed to confirm 
each modification before and after sodium borohydride reduction.  For further 
investigation of the mechanisms and structures of each modification, prolonged 
incubation and model reactions using Nα-tert-butoxycarbonyl-amino acids were 
performed.  13-HPODE and [13C18]-13-HPODE were prepared using soybean lipoxidase 
from LA and [13C18]-LA, respectively.  The mixture of 13-HPODE and 
[13C18]-13-HPODE was purified using normal phase LC system, and their combined 
concentration was determined by UV spectroscopy.  A mixture (1:1) of 13-HPODE and 
[13C18]-13-HPODE was then allowed to react with Ang II or human serum albumin 
(HSA) in the presence of L-ascorbic acid (AscA).  The major modifications derived from 
LA peroxidation were determined and the settings of IDDS were optimized by analyzing 
the reaction mixtures.  MCF-7 cells were cultured with [13C18]-LA-albumin and the 
conditions were optimized for the cells to produce a 1:1 ratio of LA and [13C18]-LA by 
monitoring LA-containing major phospholipids (PLs) in the cells.  Total lipid extraction 
was performed by Bligh-Dyer method and the resulting lipids were purified on Oasis 
HLB cartridge columns.  The sample was analyzed by LC/ESI-selected reaction 
monitoring (SRM)/MS in the negative ion mode.  Fragment ions arising from sn-1 and 
sn-2 positions were used for Q3 ions.  The SILFAC cells were treated with calcium 
ionophore A23187 and AscA at 37 °C for 24 h.  The cells were lysed in CelLytic M 
buffer containing protease and phosphatase inhibitor cocktail and the proteins were 
extracted.  After acetone purification, the pellets were dissolved in 8 M urea.  The 
solution was reduced and alkylated with dithiothreitol and iodoacetamide, respectively.  
Trypsin was added in a ratio of 1:50 (w/w) after 10–fold dilution with 50 mM ammonium 
bicarbonate, followed by incubation overnight at 37 °C.  A portion of the sample (1 µL) 
was analyzed by LC/ESI-MS/MS or LC/ESI-IDDS/MS.  Data were analyzed using 
Proteome Discoverer 1.3.  Peak list was searched by Mascot 2.3.01 against 
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UniProtKB/Swiss-Prot (2014_11, 547085 sequences). 
 
[Results] 
The most abundant ONE-derived modification to Ang II was pyruvamide-Ang II 
(Ang P) that formed via oxidative decarboxylation of N-terminal Asp.  It was followed 
by [Arg2(ONE−H2O)]-Ang II and a 4-ketoamide form of [N-ONE]-Ang II.  Michael 
addition product of [His6(HNE)]-Ang II and dehydrated Michael addition product of 
[His6(HNE−H2O)]-Ang II were major HNE-derived modifications.  The specific 
conformation of Ang II induced dehydration of the Michael addition product.  EDE 
preferentially modified the N-terminus and His6 of Ang II.  In addition to the 
N-substituted pyrrole of [N-C4H2]-Ang II and Michael addition products of 
[His6(EDE)]-Ang II, their hydrated forms were detected as major products.  
Substantial amounts of [N-(EDE−H2O)]-Ang II isomers were also formed.  The main 
HPNE-derived products were [His6(HPNE)]-Ang II and [N-(HPNE−H2O)]-Ang II.  
However, ONE, HNE, and malondialdehyde-derived modifications were dominant, 
because HPNE is a precursor of these aldehydes.  These modified Ang IIs were 
detected as predominant products in the reaction between Ang II and 13-HPODE 
mixture.  The characteristic isotope pattern (12C:13C=1:1) observed in MS spectra and 
the mass difference of the [M + H]+ doublet also aided the identification of 
[N-(9,12-dioxo-10(E)-dodecenoic acid)]-Ang II and [His6(9-hydroxy-12-oxo-10(E)- 
dodecenoic acid)]-Ang II as major LA-derived modifications.  IDDS was optimized to 
trigger when the doublet with corresponding mass difference (e.g. 4.5 Da for double 
charged ions of ONE, HNE, and HPNE-adducts) and a ratio of 1:1 were detected in the 
survey scan.  The optimal match tolerance for the intensity of the doublet was 
determined to be 0.15.  The exclusion mass width was then adjusted to avoid triggering 
a data dependent scan of interfering peaks.  When the value was set at ± 5 ppm, 
interfering peaks were excluded effectively.  Using the current settings, it was possible 
to screen all the major 13-HPODE-derived modifications to Ang II and HSA.  As for 
HSA, IDDS (ΔDa=4.514 and 3.009) revealed 9 (ONE × 2 and HPNE × 7) and 24 (ONE × 
1, HNE × 2, and HPNE × 21) modifications, respectively.  After the optimization of 
SRM conditions for the analysis of PLs, time course experiment was performed to 
determine the optimal time for incorporation of [13C18]-LA into MCF-7 cells.  The 
metabolic incorporation was observed after 6 h of incubation and reached its maximum 
level in 72 h.  SILFAC was achieved by three times of [13C18]-LA-albumin treatment 
(1.4 µM) in 120 h, followed by one subculture.  Finally, global screening using SILFAC 
and LC/ESI-IDDS/MS identified the presence of 133 modified peptides.  Among them, 
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104 peptides were identified only by IDDS.   
 
[Discussion] 
Many studies have suggested that the N-terminal Asp1, Arg2, and His6 of Ang II 
play key roles in its biological activity and receptor binding.  Therefore, Ang II 
modifications identified in this study could modulate its functions in vivo.  Indeed, Ang 
P was shown to disrupt the interaction with the Ang II type I receptor, and it did not 
undergo further metabolism via aminopeptidase A, which converts Ang II to Ang III.  
The presence of ONE, HNE, and HPNE-derived modifications in the 13-HPODE 
mixture-treated HSA suggests that these modifications could occur in vivo and serve as 
biomarkers of lipid hydroperoxide-mediated damage.  
To screen such modifications effectively, conditions for IDDS were optimized and 
SILFAC was developed by incubating MCF-7 cells with [13C18]-LA-albumin.  It is 
important to control the cell culture to produce LA and [13C18]-LA in a constant ratio, 
such as 1:1 in the present study.  Their hydroperoxides, 13-HPODE and 
[13C18]-13-HPODE (1:1) generate reactive aldehydes as a mixture of 12C and 13C isomers 
(1:1), which react with proteins in the cells and produce modified proteins as a mixture 
of 12C and 13C isomers (1:1).  The isotope mass intensity ratio (1:1) and mass difference 
of the [M + H]+ doublet are critical factors to trigger IDDS.  Although the ratio of LA 
and [13C18]-LA was maintained to be 1:1 until the cell were subjected to oxidative stress, 
ratios of modified protein produced were found to be slightly altered.  This alteration 
could be caused by the metabolic conversion of [13C18]-LA to [12C2, 13C18]-arachidonic acid 
(AA), and decomposition of endogenous AA to generate identical reactive aldehydes.  
The problem was overcome by modulating the setting of match tolerance for IDDS.   
It was shown that the current screening strategy using SILFAC and IDDS can be 
applied to cell systems without complicated enrichment procedure.  IDDS also help to 
reduce data analysis time by filtering only modified peptides for MS/MS.  Therefore, 
this proteomic screening methodology can be a powerful tool for fast and comprehensive 
identification of lipid hydroperoxide-mediated protein modifications, which facilitates 
uncovering novel biomarkers for lipid peroxidation in various cell systems.  
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